Omer Uslukaya1, Ahmet Turkoglu2, Umit Can Yazgan3, Ibrahim Kaplan4, Ibrahim Ibiloglu5, Murat Kapan2, Metehan Gumus2. 1. Departmant of General Surgery, Dicle University Medical Faculty, 21280, Diyarbakir, Turkey. druslukaya@gmail.com. 2. Departmant of General Surgery, Dicle University Medical Faculty, 21280, Diyarbakir, Turkey. 3. Department of Physiology, Zirve University Medical Faculty, Gaziantep, Turkey. 4. Department of Biochemistry, Dicle University Medical Faculty, 21280, Diyarbakir, Turkey. 5. Department of Pathology, Dicle University Medical Faculty, 21280, Diyarbakir, Turkey.
Abstract
PURPOSE: Systemic damage in acute pancreatitis (AP) can be characterized by oxidative stress and the release of pro-inflammatory cytokines. Roflumilast has been shown to be a potent anti-inflammatory and antioxidant agent. In the present study, we aimed to investigate the effect of roflumilast in cerulein-induced AP. METHODS: Thirty-two male rats were divided into four groups: group 1 (sham), group 2 (Roflumilast), group 3 (AP), and group 4 (AP + Roflumilast). AP was induced by injecting 4 × 75 μg/kg of body weight at an interval of 1 h. Rats were killed after 12 h following the last cerulein administration. AP was confirmed by measuring the serum amylase level and inflammatory features. RESULTS: Morphological changes were observed in the pancreas. Amylase levels were higher in the AP and AP + Roflumilast groups than the sham and Roflumilast groups. The serum levels of TNF-α, IL-1β, and IL-6 increased in the AP group, whereas they decreased in the Roflumilast group. The total oxidant activity (TOA) was higher and the total antioxidant capacity (TAC) was lower in the AP group. The administration of roflumilast decreased the TOA and increased the TAC in comparison with the AP group (p < 0.05 for both). CONCLUSIONS: Roflumilast significantly decreases oxidative stress and inflammatory mediators in the plasma, pancreas, and lung in cerulein-induced AP rats.
PURPOSE: Systemic damage in acute pancreatitis (AP) can be characterized by oxidative stress and the release of pro-inflammatory cytokines. Roflumilast has been shown to be a potent anti-inflammatory and antioxidant agent. In the present study, we aimed to investigate the effect of roflumilast in cerulein-induced AP. METHODS: Thirty-two male rats were divided into four groups: group 1 (sham), group 2 (Roflumilast), group 3 (AP), and group 4 (AP + Roflumilast). AP was induced by injecting 4 × 75 μg/kg of body weight at an interval of 1 h. Rats were killed after 12 h following the last cerulein administration. AP was confirmed by measuring the serum amylase level and inflammatory features. RESULTS: Morphological changes were observed in the pancreas. Amylase levels were higher in the AP and AP + Roflumilast groups than the sham and Roflumilast groups. The serum levels of TNF-α, IL-1β, and IL-6 increased in the AP group, whereas they decreased in the Roflumilast group. The total oxidant activity (TOA) was higher and the total antioxidant capacity (TAC) was lower in the AP group. The administration of roflumilast decreased the TOA and increased the TAC in comparison with the AP group (p < 0.05 for both). CONCLUSIONS: Roflumilast significantly decreases oxidative stress and inflammatory mediators in the plasma, pancreas, and lung in cerulein-induced AP rats.
Authors: Akın Onder; Murat Kapan; Metehan Gümüş; Hatice Yüksel; Abdullah Böyük; Harun Alp; Mustafa Kemal Başarili; Uğur Firat Journal: Turk J Gastroenterol Date: 2012-04 Impact factor: 1.852
Authors: P K Chatterjee; S Cuzzocrea; P A Brown; K Zacharowski; K N Stewart; H Mota-Filipe; C Thiemermann Journal: Kidney Int Date: 2000-08 Impact factor: 10.612
Authors: Robert Hermann; Nassr Nassr; Gezim Lahu; Eva Péterfai; Dietrich Knoerzer; Rolf Herzog; Karl Zech; Christian de Mey Journal: Clin Pharmacokinet Date: 2007 Impact factor: 6.447